Abstract: An operation method of a receiving terminal in sidelink communications may comprise: receiving one or more transport blocks (TBs) from a transmitting terminal; generating hybrid automatic repeat request (HARQ) responses for code block groups (CBGs) included in each of the one or more TBs; selecting one or more HARQ responses from among the HARQ responses based on priorities; and transmitting the one or more HARQ responses to the transmitting terminal through a physical sidelink feedback channel (PSFCH) resource.

Abstract: One embodiment provides a system controller circuitry for mitigating a neurophysiological disorder. The system controller circuitry includes an optimization module, a feedback control module, and a model update module. The optimization module is configured to predict a sequence of control inputs based, at least in part, on a fractional order model of a neurophysiological system. A duration of the predicted sequence of control inputs corresponds to a prediction horizon. The feedback control module is configured to provide at least a portion of the sequence of control inputs to the neurophysiological system based, at least in part, on a current state of the neurophysiological system. A duration of the at least a portion corresponds to a control horizon. The model update module is configured to update one or more of a model parameter and/or an objective function parameter at an update interval, based, at least in part, on a recent state of the neurophysiological system.

Abstract: A video signal processing method may comprise the steps of: confirming a prediction mode applied to a current coding unit; confirming whether a plurality of preset conditions are satisfied on the basis of at least one of the prediction mode of the current coding unit and a size of the current coding unit; parsing a first syntax element indicating a transform kernel applied to a transform unit included in the current coding unit when the plurality of preset conditions are satisfied; determining a transform kernel applied to horizontal and vertical directions of the current transform unit on the basis of the first syntax element; and generating a residual signal of the current transform unit by performing an inverse transform on the current transform unit using the determined transform kernel.

Abstract: An operation method of a terminal in a communication system may comprise receiving, from a base station, first information indication suspension of a physical downlink control channel (PDCCH) monitoring operation; in response to the first information, suspending the PDCCH monitoring operation in a first period; and restarting the PDCCH monitoring operation after the first period ends.

Abstract: The present invention provides novel compounds of Formulae (I?) and (II), and pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, isotopically labeled derivatives, prodrugs, and compositions thereof. Also provided are methods and kits involving the inventive compounds or compositions for treating and/or preventing proliferative diseases (e.g., cancers (e.g., leukemia, acute lymphoblastic leukemia, lymphoma, Burkitt's lymphoma, melanoma, multiple myeloma, breast cancer, Ewing's sarcoma, osteosarcoma, brain cancer, ovarian cancer, neuroblastoma, lung cancer, colorectal cancer), benign neoplasms, diseases associated with angiogenesis, inflammatory diseases, autoinflammatory diseases, and autoimmune diseases) in a subject. Treatment of a subject with a proliferative disease using a compound or composition of the invention may inhibit the aberrant activity of a kinase, such as a cyclin-dependent kinase (CDK) (e.g.

Abstract: The present invention provides novel compounds of Formula (I), and pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, isotopically labeled derivatives, prodrugs, and compositions thereof. Also provided are methods and kits involving the inventive compounds or compositions for treating or preventing proliferative diseases (e.g., cancers (e.g., lung cancer, breast cancer, leukemia, lymphoma, melanoma, multiple myeloma, Ewing's sarcoma, osteosarcoma, brain cancer, neuroblastoma), benign neoplasms, angiogenesis, inflammatory diseases, autoinflammatory diseases, and autoimmune diseases) in a subject. Treatment of a subject with a proliferative disease using a compound or composition of the invention may inhibit the aberrant activity of a kinase (e.g. a protein kinase (e.g. a cyclin-dependent kinase (CDK) (e.g. CDK7, CDK12, or CDK13) or a lipid kinase such as a phosphatidylinositol-5-phosphate 4-kinase (PIP4K) (e.g.

Abstract: Systems and methods for a powered, robotic exoskeleton, or exosuit, for a user's limbs and body are provided. The exosuit may be equipped with airbag devices mounted at various locations on the suit. The exosuit may include on-board computing equipment that can sense, compute control commands in real-time, and actuate limbs and airbags to restore stability (fall prevention) and minimize injuries due to falls, should they happen (fall protection).

Abstract: The present disclosure describes combination therapies for breast cancer comprising an oligonucleotide toll-like receptor 9 agonist and a PD-1 antagonist. In particular, the present disclosure describes combinations of a CpG-C type oligonucleotide and an anti-PD-1 antibody for the treatment of breast cancer. The combination may further comprise a taxane chemotherapeutic agent, in the presence or absence of a corticosteroid.

Abstract: A method performed by an autonomous vehicle includes identifying a condition preventing the autonomous vehicle from proceeding along an intended route. The method also includes prompting a passenger of the autonomous vehicle to interact with a driver of a first vehicle in response to identifying the condition. The method further includes receiving, from the passenger, an input at an interface of the autonomous vehicle indicating a successful interaction or an unsuccessful interaction with the driver. The method also includes controlling the autonomous vehicle to proceed along the intended route based on the input indicating the successful interaction with the driver.

Abstract: A method for depth estimation performed by a depth estimation system of an autonomous agent includes determining a first pose of a sensor based on a first image captured by the sensor and a second image captured by the sensor. The method also includes determining a first depth of the first image and a second depth of the second image. The method further includes generating a warped depth image based on at least the first depth and the first pose. The method still further includes determining a second pose based on the warped depth image and the second depth image. The method also includes updating the first pose based on the second pose and updating a first warped image based on the updated first pose.

Abstract: Disclosed herein are methods and compositions for treating a subject having or at risk of having an HIV infection. Disclosed herein are peptide immunogens and nucleic acids that have epitopes in which mutations are most likely to have deleterious effects on the HIV virus. An algorithm is disclosed for the selection of the epitopes based on the HIV fitness landscape, and it accounts for the effect of coupling mutations.

Abstract: The present invention discloses magnesia and a method for manufacturing same, wherein the magnesia can be produced into granules of various shapes and sizes and can be improved in moisture resistance with the formation of a moisture resistant surface oxide layer by donor addition and then thermal treatment. The magnesia according to the present invention comprises a MgO granule; and a surface oxide layer formed on a surface of the MgO granule and a composition of the surface oxide layer is different from a composition of an inside of the MgO granule.

Abstract: A microorganism having at least one SPX gene encoding SPX protein responsive to phosphorus deficiency, and characterized in that a function of the SPX protein is decreased or lost by introducing gene mutation into the SPX gene.

Abstract: A measurement device according to one embodiment of the present invention, comprises: a voltage applying part for applying a voltage between electrodes of a biosensor, the biosensor comprising a solid electrolyte and at least two electrodes, and being configured such that the solid electrolyte and the electrodes are in contact with each other; a detection part for measuring a current value flowing between the electrodes when the voltage is applied; and a computing part for providing information resulting from the microorganisms by comparing the current value with a reference value stored in advance in which a current value and at least one type of factor selected from the group consisting of the presence or absence of the biological particles, a proliferative state of the microorganisms, and the presence or absence of expression of pathogenicity of the microorganisms are defined.

Abstract: A process for forming extruded products using a device having a scroll face configured to apply a rotational shearing force and an axial extrusion force to the same preselected location on material wherein a combination of the rotational shearing force and the axial extrusion force upon the same location cause a portion of the material to plasticize, flow and recombine in desired configurations. This process provides for a significant number of advantages and industrial applications, including but not limited to extruding tubes used for vehicle components with 50 to 100 percent greater ductility and energy absorption over conventional extrusion technologies, while dramatically reducing manufacturing costs.

Abstract: A pharmaceutical composition and a health functional food composition for preventing, treating, or improving muscular diseases have licorice extract or a fraction thereof, or a compound isolated therefrom or a pharmaceutically acceptable salt thereof, as an active ingredient. The licorice extract or a fraction thereof, the compound or salt thereof induce the myoblasts proliferation and promote the differentiation into myotubes, and since the licorice extract or a fraction thereof, the compound or salt thereof has an excellent effect on regenerating damaged muscles, various muscle diseases are effectively prevented, improved or treated using the composition.

Abstract: The present disclosure relates to an improved methodology for phenotyping and molecular characterisation of single cells using high-throughput and multiplexed targeted long-read single cell sequencing. In one particular example, the present disclosure relates to a methodology which combines targeted long-read sequencing with short-read based transcriptome profiling of barcoded single cell libraries generated by droplet-based partitioning for high throughput deep single cell profiling.

Abstract: The technology described herein is directed to IL-4 and/or IL-13 inhibitors and uses thereof.

Abstract: A speech processing apparatus includes a plurality of microphones configured to receive a plurality of input signals, and processing circuitry configured to generate a spatial filtering signal corresponding to the plurality of input signals through spatial filtering, generate estimated noise information by integrating directional noise information representing a level of a noise signal received from a direction of interest with diffuse noise information representing levels of noise signals received from various directions based on whether the plurality of input signals have directionality, and generate an estimated speech signal by filtering the spatial filtering signal based on the estimated noise information.

Abstract: Provided is a multi-agent based manned-unmanned collaboration system including: a plurality of autonomous driving robots configured to form a mesh network with neighboring autonomous driving robots, acquire visual information for generating situation recognition and spatial map information, and acquire distance information from the neighboring autonomous driving robots to generate location information in real time; a collaborative agent configured to construct location positioning information of a collaboration object, target recognition information, and spatial map information from the visual information, the location information, and the distance information collected from the autonomous driving robots, and provide information for supporting battlefield situational recognition, threat determination, and command decision using the generated spatial map information and the generated location information of the autonomous driving robot; and a plurality of smart helmets configured to display the location positi